RBMY2WP

Across TCGA pan-cancer cohorts, RBMY2WP RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RBMY2WP data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RBMY2WP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RBMY2WP expression acts as an unfavorable survival marker.

TGCT and LGG are the cancer types where RBMY2WP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
LGG	OS	Tertile	All	0.425	0.811	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RBMY2WP–TGCT (DFS)

Open the TGCT breakdown →